<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02073669</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-13-0668-DS-CTIL</org_study_id>
    <nct_id>NCT02073669</nct_id>
  </id_info>
  <brief_title>Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults</brief_title>
  <official_title>Better Identification of Latent Tuberculosis Infection Among Israeli Young Adults by Comparison Skin Tests and Interferon Gamma Releasing Assays (IGRA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel Aviv Lung Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of study is to evaluate the prevalence of latent TB in second generation immigrants
      from countries with high incidence of tuberculosis (above 20 of 100,000) compare to the
      control native Israelis without a family member who was born in a country with high incidence
      of tuberculosis. Using study questionnaire IGRA and tuberculin skin test the investigators
      expect that the second generation immigrants group will have more positive IGRA test than the
      control native group.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Interferon gamma release assay ( IGRA)</measure>
    <time_frame>Up to 3 months after tuberculin skin test</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Latent Tuberculosis</condition>
  <arm_group>
    <arm_group_label>Second generation immigrants from high TB incidence countries</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Native Israelis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)</intervention_name>
    <arm_group_label>Second generation immigrants from high TB incidence countries</arm_group_label>
    <arm_group_label>Native Israelis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-25

          -  Men and women

          -  Second generation immigrants from countries with high incidence of tuberculosis (above
             20 of 100,000).

          -  Native Israelis without a family member who was born in a country with high incidence
             of tuberculosis.

        Exclusion Criteria:

          -  Prior contact with a tuberculosis patient

          -  Working (more than a month) in high risk setting such as health care workers, working
             with immigrants from countries with high incidence of tuberculosis.

          -  HIV infection and any immunodeficiency condition.

          -  Recent live-virus vaccination

          -  Acute infectious disease

          -  Prior serious reaction to tuberculin skin test

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dekel Shlomi, M.D.</last_name>
    <phone>972-3-5302339</phone>
    <email>dekel.shlomi@sheba.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dekel Shlomi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Israeli Defense Forces</name>
      <address>
        <city>Ramat-Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2014</study_first_submitted>
  <study_first_submitted_qc>February 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2014</study_first_posted>
  <last_update_submitted>October 6, 2017</last_update_submitted>
  <last_update_submitted_qc>October 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>latent tuberculosis</keyword>
  <keyword>tuberculin skin test</keyword>
  <keyword>Interferon gamma release assay</keyword>
  <keyword>immigration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Latent Tuberculosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferons</mesh_term>
    <mesh_term>Interferon-gamma</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

